Denmark Biochip Market Size & Outlook, 2025-2030

The biochip market in Denmark is expected to reach a projected revenue of US$ 300.9 million by 2030. A compound annual growth rate of 8.2% is expected of Denmark biochip market from 2025 to 2030.
Revenue, 2024 (US$M)
$180.6
Forecast, 2030 (US$M)
$300.9
CAGR, 2025 - 2030
8.2%
Report Coverage
Denmark

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Denmark biochip market, 2018-2030 (US$M)

Denmark biochip market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Denmark biochip market highlights

  • The Denmark biochip market generated a revenue of USD 180.6 million in 2024 and is expected to reach USD 300.9 million by 2030.
  • The Denmark market is expected to grow at a CAGR of 8.2% from 2025 to 2030.
  • In terms of segment, dna chips was the largest revenue generating type in 2024.
  • Lab-on-chip is the most lucrative type segment registering the fastest growth during the forecast period.

Biochip market data book summary

Market revenue in 2024USD 180.6 million
Market revenue in 2030USD 300.9 million
Growth rate8.2% (CAGR from 2025 to 2030)
Largest segmentDna chips
Fastest growing segmentLab-on-chip
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDNA Chips, Protein Chips, Lab-on-chip, Tissue Arrays, Cell Arrays
Key market players worldwideAgilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox

Other key industry trends

  • In terms of revenue, Denmark accounted for 1.4% of the global biochip market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany biochip market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 2,052.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biochip Market Companies

Name Profile # Employees HQ Website
Randox View profile 1001-5000 Crumlin, Antrim, United Kingdom, Europe http://www.randox.com
PerkinElmer View profile 10001+ Waltham, Massachusetts, United States, North America http://www.perkinelmer.com
Standard BioTools Inc View profile 539 2 Tower Place, Suite 2000, South San Francisco, CA, United States, 94080 https://www.standardbio.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Agilent Technologies Inc View profile 17700 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 https://www.agilent.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
GE HealthCare Technologies Inc Common Stock View profile 51000 500 West Monroe Street, Chicago, IL, United States, 60661 https://www.gehealthcare.com

Denmark biochip market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.


Dna chips was the largest segment with a revenue share of 42.91% in 2024. Horizon Databook has segmented the Denmark biochip market based on dna chips, protein chips, lab-on-chip, tissue arrays, cell arrays covering the revenue growth of each sub-segment from 2018 to 2030.


According to the World Population Review, in 2022, Denmark was ranked 5th globally in terms of number of cancer cases. In Denmark, 334.9 people per 100,000 had cancer in 2020. Thus, the high burden of target conditions is fueling the demand for advanced therapeutics and diagnostics.

The country’s market is majorly driven by the significantly growing demand for precision medicine, rising R&D expenditure by biopharmaceutical companies, and the evolving biotechnology sector in the country. For instance, according to the Ministry of Foreign Affairs of Denmark, the country is ranked 3rd in Europe in the biotechnology sector and has the world’s greatest percentage of patents in biotechnology.

Moreover, increasing applications of proteomics in drug discovery and precision diagnostics have compelled companies to invest in proteomics technologies. For instance, in January 2023 Novo Holdings invested USD 40 million in Evosep, a leading proteomics company. 

Reasons to subscribe to Denmark biochip market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Denmark biochip market databook

  • Our clientele includes a mix of biochip market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Denmark biochip market, including forecasts for subscribers. This country databook contains high-level insights into Denmark biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Denmark biochips market size, by type, 2018-2030 (US$M)

Denmark Biochip Market Share, 2024 & 2030 (US$M)

Denmark biochips market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online